Brazil health regulator Anvisa allows Chinese COVID-19 vaccine trial

Saturday, 4 July 2020 16:32

Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.

Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.

According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.

It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.

More from International News

Gunman kills six family members in eastern Iowa, police say

A gunman has killed six members of his family, then took his own life, during a spate of shootings on Monday in the eastern Iowa city of Muscatine, a waterfront town situated across the Mississippi River from Illinois, police said.
Russian drones, missiles strike Ukraine in major attack; 10 dead, dozens wounded

Russian drones and missiles pounded Ukrainian cities such as Kyiv and Dnipro early on Tuesday, killing at least 10 people and wounding about 100, authorities said, following days of warnings about Moscow's plans for a major assault.
Trump says no Israeli troops will go to Beirut after call with Netanyahu

US President Donald Trump said on Monday that Israel would not send troops to Beirut after a call he held with Israeli Prime Minister Benjamin Netanyahu.
Moderna and other groups get $60 million to develop Ebola vaccine

Global health organisation CEPI will give roughly $60 million to Moderna and two other groups to accelerate the development of shots against Ebola Bundibugyo, the deadly virus that has swept through eastern Democratic Republic of Congo.